CynthiaLGrosskreutzMD
Ophthalmology • Boston, MAAssociate Professor, Ophthalmology, Harvard Medical School
Dr. Grosskreutz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
243 Charles St
Boston, MA 02114Phone+1 617-573-3674- Is this information wrong?
Education & Training
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1990 - 1993
Steward Carney HospitalInternship, Internal Medicine, 1989 - 1990
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1989
Certifications & Licensure
MA State Medical License 1993 - 2026- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Publications & Presentations
PubMed
- Retinal Dystrophy Associated With RLBP1 Retinitis Pigmentosa: A Five-Year Prospective Natural History Study.Marie Burstedt, James H Whelan, Jane S Green, Karen Holopigian, Claudio Spera, Erin Greco, Jean-Yves Deslandes, Michael Wald, Cynthia Grosskreutz, Xiao Ni, Guillaume N...> ;Investigative Ophthalmology & Visual Science. 2023 Oct 3
- 3 citationsComplement factor B is critical for sub-RPE deposit accumulation in a model of Doyne honeycomb retinal dystrophy with features of age-related macular degeneration.Maura A Crowley, Donita L Garland, Holger Sellner, Angela Banks, Lin Fan, Tomas Rejtar, Natasha Buchanan, Omar Delgado, Yong Yao Xu, Sandra Jose, Christopher M Adams, ...> ;Human Molecular Genetics. 2023 Jan 6
- 6 citationsNon-invasive molecular tracking method that measures ocular drug distribution in non-human primatesGuillaume Normand, Michael Maker, Jan Penraat, Kellyann Kovach, Joy Ghosh, Cynthia L. Grosskreutz, Sudeep Chandra> ;Communications Biology. 2020 Jan 8
- Join now to see all
Press Mentions
Novartis : Acquires Arctos Medical, Expanding Optogenetics Portfolio to Bring Gene Therapies to Patients with Severe Vision LossSeptember 23rd, 2021- Gene Therapy, High-Tech Goggles Restore Some Vision to Blind PeopleMay 24th, 2021
- Week in Review: Corneal Shield, Novartis Acquisition, Preloaded IOLNovember 6th, 2020
Grant Support
- Neuroprotection And Retinal Ganglion Cell DeathNational Eye Institute2002–2010
- Hypoxic Regulation Of Vascular Growth In VitroNational Eye Institute1997–1998
- Hypoxic Regulation Of Vascular Growth In VitroNational Eye Institute1994–1996
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
